Prevalence and Screening of Abdominal Aortic Aneurysms Among Men With Coronary Artery Disease (CAD-AAA)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01897623|
Recruitment Status : Completed
First Posted : July 12, 2013
Last Update Posted : December 17, 2014
The purpose of this study is to investigate the prevalence of abdominal aortic aneurysms (AAA) among male patients with coronary artery disease (CAD) verified in coronary angiography. Ethiology of AAA is known to be common with atherosclerotic arterial diseases (coronary artery disease, peripheral artery disease and carotid artery disease), so the hypothesis is that AAA should be more common among these CAD patients, thus making screening of these patients (for AAA) more cost-efficient.
Study will be carried out as a multi-center prospective screening study. Data will be collected in North Karelia Central Hospital, Kuopio University Hospital and Tampere University Hospital. Data consists of 200 consecutive coronary angiography patients in each hospital, resulting in 600 patients in total. All male patients with diagnosed CAD will be recruited for the study and screened for AAA with ultrasound. Nevertheless, patients with previously known AAA will be excluded from the study.
|Condition or disease||Intervention/treatment||Phase|
|Abdominal Aortic Aneurysm||Other: ultrasound of aorta||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Official Title:||Prevalence and Screening of Abdominal Aortic Aneurysms Among Men With Coronary Artery Disease|
|Study Start Date :||July 2013|
|Actual Primary Completion Date :||October 2014|
|Actual Study Completion Date :||October 2014|
|ultrasound of aorta||Other: ultrasound of aorta|
- Maximum diameter (mm) of abdominal aorta (outer-to-outer wall) in ultrasound [ Time Frame: upon screening ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01897623
|North Carelia Central Hospital|
|Joensuu, Pohjois-Karjala, Finland, 80200|